Treace Medical Concepts Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 227

Employees

  • Stock Symbol
  • TMCI

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $9.82
  • (As of Wednesday Closing)

Treace Medical Concepts General Information

Description

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Contact Information

Website
www.treace.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Palmetto Park Place
  • Ponte Vedra Beach, FL 32081
  • United States
+1 (904)
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 100 Palmetto Park Place
  • Ponte Vedra Beach, FL 32081
  • United States
+1 (904)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Treace Medical Concepts Stock Performance

As of 12-Feb-2025, Treace Medical Concepts’s stock price is $9.82. Its current market cap is $612M with 62.2M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.82 $10.00 $3.92 - $15.97 $612M 62.2M 389K -$0.99

Treace Medical Concepts Financials Summary

As of 30-Sep-2024, Treace Medical Concepts has a trailing 12-month revenue of $203M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 335,510 734,691 1,259,431 911,000
Revenue 202,861 187,118 141,838 94,419
EBITDA (54,013) (45,734) (37,597) (15,824)
Net Income (61,523) (49,527) (42,815) (20,552)
Total Assets 212,924 251,907 159,024 140,821
Total Debt 70,121 70,303 68,589 29,365
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Treace Medical Concepts Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Treace Medical Concepts‘s full profile, request access.

Request a free trial

Treace Medical Concepts Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Treace Medical Concepts‘s full profile, request access.

Request a free trial

Treace Medical Concepts Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the sta
Surgical Devices
Ponte Vedra Beach, FL
227 As of 2023

Englewood, CO
 

Lewisville, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Treace Medical Concepts Competitors (28)

One of Treace Medical Concepts’s 28 competitors is Paragon 28, a Formerly VC-backed company based in Englewood, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Paragon 28 Formerly VC-backed Englewood, CO
Orthofix International Formerly PE-Backed Lewisville, TX
Spine Wave Venture Capital-Backed Shelton, CT
Alpha-Stim Private Equity-Backed Mineral Wells, TX
Corin Group Private Equity-Backed Cirencester, United Kingdom
You’re viewing 5 of 28 competitors. Get the full list »

Treace Medical Concepts Patents

Treace Medical Concepts Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250017604-A1 Osteotomy systems and techniques for treating metatarsal misalignment Pending 14-Jul-2023
US-20240277350-A1 Apparatus, system, and method for patient-specific harvesting guide Pending 21-Feb-2023
US-20240282221-A1 Apparatus, system, and method for patient-specific models Pending 17-Feb-2023
US-20240268966-A1 Apparatus, system, and method for lapidus correction Pending 11-Feb-2023
US-20240307076-A1 Pinning and drilling instruments for small bone implant placement Pending 08-Feb-2023 A61B17/1775
To view Treace Medical Concepts’s complete patent history, request access »

Treace Medical Concepts Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Treace Medical Concepts Investments (1)

Treace Medical Concepts’s most recent deal was a Corporate Asset Purchase with RedPoint Medical 3D (Patient Specific Instrumentation Technology) for . The deal was made on 12-Jun-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
RedPoint Medical 3D (Patient Specific Instrumentation Technology) 12-Jun-2023 Corporate Asset Purchase Surgical Devices
To view Treace Medical Concepts’s complete investments history, request access »

Treace Medical Concepts ESG

Risk Overview

Risk Rating

Updated November, 14, 2023

27.84 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,120

Rank

Percentile

Healthcare

Industry

of 587

Rank

Percentile

Medical Devices

Subindustry

of 199

Rank

Percentile

To view Treace Medical Concepts’s complete esg history, request access »

Treace Medical Concepts FAQs

  • When was Treace Medical Concepts founded?

    Treace Medical Concepts was founded in 2013.

  • Where is Treace Medical Concepts headquartered?

    Treace Medical Concepts is headquartered in Ponte Vedra Beach, FL.

  • What is the size of Treace Medical Concepts?

    Treace Medical Concepts has 227 total employees.

  • What industry is Treace Medical Concepts in?

    Treace Medical Concepts’s primary industry is Surgical Devices.

  • Is Treace Medical Concepts a private or public company?

    Treace Medical Concepts is a Public company.

  • What is Treace Medical Concepts’s stock symbol?

    The ticker symbol for Treace Medical Concepts is TMCI.

  • What is the current stock price of Treace Medical Concepts?

    As of 12-Feb-2025 the stock price of Treace Medical Concepts is $9.82.

  • What is the current market cap of Treace Medical Concepts?

    The current market capitalization of Treace Medical Concepts is $612M.

  • What is Treace Medical Concepts’s current revenue?

    The trailing twelve month revenue for Treace Medical Concepts is $203M.

  • Who are Treace Medical Concepts’s competitors?

    Paragon 28, Orthofix International, Spine Wave, Alpha-Stim, and Corin Group are some of the 28 competitors of Treace Medical Concepts.

  • What is Treace Medical Concepts’s annual earnings per share (EPS)?

    Treace Medical Concepts’s EPS for 12 months was -$0.99.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »